Cardiovascular Disease Burden in Type 2 Diabetes: Strategies to Improve Outcomes

The American Diabetes Association’s Standards of Care in Diabetes—2024Подробнее

Reducing cardiovascular risk in type 2 diabetes by glucose lowering – does the drug matter?Подробнее

Research Update: Improving Lives Part 2Подробнее

Webinar: Diabetes Reversal, Benefits Beyond Metabolic Health (9/14/22)Подробнее

Traditional and Female-Specific Risk Factors that Influence A Woman’s Cardiovascular RiskПодробнее

Diabetes and the Heart. ESC Guidelines: Part 2Подробнее

Know Diabetes by Heart: Team-Based Care Strategies to Improve Patient OutcomesПодробнее

Darren K. McGuire | Antihyperglycemic Medications for Cardiovascular Risk ReductionПодробнее

English: Diabetes and ASCVD | Medurstand by Prof Aziz ur RehmanПодробнее

Overview Of Diabetes Webinar - Lisa SparksПодробнее

New Goals and Therapeutic Options for Type 2 Diabetes MellitusПодробнее

Diabetes trials: challenges and current directionsПодробнее

Medicine Grand Rounds: Diabetes and Cardiovascular Disease 3/26/19Подробнее

Type 2 Diabetes: New Guidelines and ControversiesПодробнее

Prevention of Cardiovascular DiseaseПодробнее

SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"Подробнее

Internal Medicine Grand Rounds: New Goals and Therapeutic Options for Type 2 DiabetesПодробнее

UCC presents Professor Neil R Poulter CV Outcome Trials in Type 2 Diabetes: A ReviewПодробнее

Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap Forward in Optimizing Patient Care?Подробнее